Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies

Ofrat Beyar Katz, Roni Bitterman, Tsila Zuckerman, Yishai Ofran, Dafna Yahav, Leonard Leibovici, Mical Paul

Research output: Contribution to journalArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: We will assess the effects of anti-herpes drugs in hemato-oncological patients comparing prophylaxis versus placebo, no treatment or pre-emptive treatment.

Original languageEnglish
Article numberCD012601
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number3
DOIs
StatePublished - 18 Mar 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies'. Together they form a unique fingerprint.

Cite this